Endoceutics is a Canadian biotechnology, healthcare, and pharmaceutical company founded in 2006. With a team of 110 employees, the company focuses on women's health, as well as the prevention and treatment of hormono-sensitive cancers. Endoceutics has its own drug manufacturing facilities, bio-analytical laboratories, and expertise in clinical development, registration, and commercialization of its products. The company boasts a portfolio of products at different stages of development and is committed to improving the quality of life for women. Currently, there is no public information available regarding Endoceutics' last investment or its investors.
There is no investment information
No recent news or press coverage available for Endoceutics.
We care about your data, and we'd love to use cookies make your experience better.
